bird flu vaccine moderna - Search News

News

Moderna, influenza vaccine

Zacks Investment Research on M… · 1h

Moderna Stock Gains on Encouraging Flu Vaccine Data

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III efficacy study (P304) in adults aged 50 and above.

The Boston Globe · 21h

Moderna’s flu vaccine hits goal, paving way for combo shot

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Moderna announces promising efficacy results from mRNA flu vaccine trial

Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu vaccine candidate compared to a standard-dose licensed flu vaccine in adults ages 50 years and older.

American Council on Science and Health2hOpinion

A Dangerous Gamble: The U.S. Abandons Bird Flu Vaccine Preparedness

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

STAT1dOpinion

The U.S. must invest in mRNA vaccines against pandemic influenza viruses now

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Honolulu Star-Advertiser12d

Senate Democrats demand RFK Jr. explain canceled bird flu vaccine

WASHINGTON >> U.S. Senate Democrats demanded today that Health Secretary Robert F. Kennedy Jr. make public the reviews on ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results